Matrix Metalloproteinase Inspired Therapeutic Strategies for Bone Diseases

Author(s): Longfa Kou, Xinyu Jiang, Xinlu Lin, Huirong Huang, Jun Wang, Qing Yao*, Ruijie Chen*

Journal Name: Current Pharmaceutical Biotechnology

Volume 22 , Issue 4 , 2021

Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


Matrix Metalloproteinases (MMPs), as a family of zinc-containing enzymes, show the function of decomposing Extracellular Matrix (ECM) and participate in the physiological processes of cell migration, growth, inflammation, and metabolism. Clinical and experimental studies have indicated that MMPs play an essential role in tissue injury and repair as well as tumor diagnosis, metastasis, and prognosis. An increasing number of researchers have paid attention to their functions and mechanisms in bone health and diseases. The present review focuses on MMPs-inspired therapeutic strategies for the treatment of bone-related diseases. We introduce the role of MMPs in bone diseases, highlight the MMPs-inspired therapeutic options, and posit MMPs as a trigger for smart cell/drug delivery.

Keywords: Matrix metalloproteinase, bone disease, drug delivery, hydrogel, nanomedicine, MMP-responsive.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2021
Published on: 27 April, 2021
Page: [451 - 467]
Pages: 17
DOI: 10.2174/1389201021666200630140735
Price: $65

Article Metrics

PDF: 21